Burcon Nutrascience Corp (BU.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
(Values in thousands)
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 161 | 180 | 167 | 158 | 155 |
| Accounts receivable | 163 | 226 | -212 | -87 | -58 |
| Other Working Capital | 195 | 526 | -124 | -102 | -538 |
| Other Operating Activity | -1,746 | -1,906 | -1,111 | -1,560 | -1,730 |
| Operating Cash Flow | $-1,227 | $-974 | $-1,280 | $-1,590 | $-2,171 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -23 | -39 | -267 | -45 | -8 |
| Other Investing Activity | 27 | 11 | 11 | -944 | -3,153 |
| Investing Cash Flow | $4 | $-29 | $-257 | $-989 | $-3,161 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 1,000 | 2,000 | N/A | N/A |
| Debt Repayment | -4 | 61 | -25 | -25 | -25 |
| Common Stock Issued | 3,413 | 0 | 0 | 0 | 0 |
| Other Financing Activity | -45 | -212 | 75 | 2,047 | 0 |
| Financing Cash Flow | $3,365 | $849 | $2,050 | $2,022 | $-25 |
| Exchange Rate Effect | -27 | 2 | 0 | 11 | -3 |
| Beginning Cash Position | 1,457 | 1,609 | 1,096 | 1,641 | 7,001 |
| End Cash Position | 3,572 | 1,457 | 1,609 | 1,096 | 1,641 |
| Net Cash Flow | $2,142 | $-154 | $513 | $-557 | $-5,357 |
| Free Cash Flow | |||||
| Operating Cash Flow | -1,227 | -974 | -1,280 | -1,590 | -2,171 |
| Capital Expenditure | -23 | -39 | -267 | -45 | -8 |
| Free Cash Flow | -1,250 | -1,014 | -1,548 | -1,635 | -2,179 |